Evidence map›Paper›PMID 26712474›Full record

Trial reportAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2016

Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment.

Wilson Quezada, Eun Soo Kwak, Joan Reibman, Linda Rogers, John Mastronarde, William G Teague, Christine Wei, Janet T Holbrook, Emily DiMango

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Current unmet needs and potential solutions to uncontrolled asthma.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Assessing health outcomes, quality of life, and healthcare use among school-age children with asthma.The Journal of asthma : official journal of the Association for the Care of Asthma · 2019
    Article
  14. Article
  15. Factors Predicting Recovery From Asthma Exacerbations.Allergy, asthma & immunology research · 2016
    Article
  16. Article
  17. Asthma Exacerbations: Pathogenesis, Prevention, and Treatment.The journal of allergy and clinical immunology. In practice
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Wilson QuezadaDepartment of Medicine, Columbia University Medical Center, New York, New York.
Eun Soo KwakDepartment of Medicine, Columbia University Medical Center, New York, New York.
Joan ReibmanNew York University of Medicine, New York, New York.
Linda RogersMount Sinai School of Medicine, New York, New York.
John MastronardeOhio State University, Columbus, Ohio.
William G TeagueUniversity of Virginia Medical Center, Charlottesville, Virginia.
Christine WeiJohns Hopkins University, Baltimore, Maryland.
Janet T HolbrookJohns Hopkins University, Baltimore, Maryland.
Emily DiMangoDepartment of Medicine, Columbia University Medical Center, New York, New York. Electronic address: ead3@columbia.edu.
Columbia University Irving Medical Center · USJohns Hopkins University · USIcahn School of Medicine at Mount Sinai · USNew York University · USThe Ohio State University · USUniversity of Virginia Medical Center · US

Funding

Airway redox biochemistry as a deteriminant of asthma phenotype during adolescen*U10HL109250 · NHLBI · UNIVERSITY OF VIRGINIA · PI ERZURUM, SERPIL C., GASTON, BENJAMIN · 2011 to 2016
$4.2M
Clinical Trial of Acid Reflux Therapy in AsthmaU01HL072968 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI WISE, ROBERT A. · 2003 to 2007
$3.7M
Study of Acid Reflux Therapy for Children with AsthmaU01HL080450 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HOLBROOK, JANET T. · 2006 to 2010
$2.3M
Study of Acid Reflux Therapy for Children with AsthmaU01HL080433 · NHLBI · UNIVERSITY OF VIRGINIA · PI TEAGUE, WILLIAM GERALD · 2006 to 2010
$1.8M
NHLBI NIH HHS U01 HL072968NHLBI NIH HHS U01 HL080433NHLBI NIH HHS U01HL080433NHLBI NIH HHS U01 HL080450NHLBI NIH HHS U01HL080450NHLBI NIH HHS U10 HL109250NHLBI NIH HHS UO1HL072968
6 · The paper itself

Abstract

backgroundAsthma exacerbations are associated with decreased quality of life and increased health care usage. Identification of characteristics that predict increased risk of future exacerbations in patients with suboptimal control of asthma could guide treatment decisions.

objectiveTo examine patient characteristics associated with risk of asthma exacerbations in patients with uncontrolled persistent asthma.

methodsA retrospective analysis of adults and children with inadequately controlled asthma despite asthma controller therapy and enrolled in 2 randomized trials was conducted. Baseline characteristics of subjects who experienced an asthma exacerbation during the treatment period were compared with those of subjects who did not experience an exacerbation.

resultsOf 718 subjects (402 adults and 295 children), 108 adults (27%) and 110 children (37%) experienced an asthma exacerbation during the study period. Unscheduled health care visits for asthma or use of oral corticosteroids in the previous year were significantly associated with asthma exacerbation during the study period (P < .01). Adult subjects who experienced an exacerbation had significantly lower forced expiratory volume in 1 second compared with those who did not (2.3 vs 2.5 L, respectively, P = .02). Children who experienced an exacerbation had lower baseline pre- and post-bronchodilator ratios of forced expiratory volume in 1 second to forced vital capacity (77% vs 81%, P < .01; 82% vs 86%, P < .001, respectively). Symptom scores on validated questionnaires were significantly worse in adults but not in children who developed an exacerbation.

conclusionSpirometric measurements can help identify adults and children at increased risk for asthma exacerbation. Symptom scores could be helpful in identifying adults who are at high risk for exacerbations but could be less helpful in children.

Indexed as

Administration, InhalationAdrenal Cortex HormonesAdultAnti-Asthmatic AgentsAsthmaChildDouble-Blind MethodFemaleForced Expiratory VolumeHumansMaleSpirometrySurveys and QuestionnairesAdrenal Cortex HormonesAnti-Asthmatic Agents

Identifiers

PMID26712474
PMCPMC4731304
OpenAlexW2205572608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.